(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCO3R

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ONCO3R

ST13

US500000079427986

Class

5, 42

Filing

79427986

Registration

8226824

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

08/04/2026

Trademark type

Word

Nice classes

5, 42

Filing date

06/04/2025

Registration date

04/28/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2026

Last transaction

08/04/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

BE

Examiner

LAVACHE, LINDA M

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

ONCO3R Therapeutics (besloten vennootschap)

Representatives

Clifford D. Hyra Fresh IP PLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and therapeutical preparations and medications for the treatment and prevention of oncological and immunological diseases and conditions; pharmaceuticals and medicines for treating oncological and immunological disorders

Class 42

Medical and pharmacological research services; pharmaceutical research and development of pharmaceuticals and medicines; pharmaceutical research and development of pharmaceuticals and medicines for treating oncological and immunological disorders

Publications

History of USPTO decisions and trademark events.

21 publications found

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

08/04/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/28/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/28/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2026

PUBO

PUBLISHED FOR OPPOSITION

03/10/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/04/2026

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

02/26/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/18/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/17/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/17/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/17/2026

RFNT

REFUSAL PROCESSED BY IB

12/25/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/08/2025

RFRR

REFUSAL PROCESSED BY MPU

12/08/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/30/2025

CNRT

NON-FINAL ACTION WRITTEN

10/29/2025

DOCK

ASSIGNED TO EXAMINER

10/23/2025

MAFR

APPLICATION FILING RECEIPT MAILED

07/18/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/18/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/17/2025

Continuous trademark protection

Get notified about every new filing that threatens ONCO3R or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.